| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.27 | 0.05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |